Patients carrying heterozygous mutations of BRPF1 suffer from a neurodevelopmental disorder characterized by congenital hypotonia, facial dysmorphisms, global developmental delay, and ID (Yan et al., 2017), which suggests that Brpf1 may regulate brain development in a dosage-dependent manner. Here, BRPF1 is linked to neurodevelopmental disorder.